-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to statistics, the number of people with inflammatory bowel disease (IBD) in the U.
S.
adult population is approximately 3.
1 million.
Diverticulitis is a common gastrointestinal disease.
Current epidemiological studies have shown that the diagnosis of diverticulitis is related to The incidence of IBD is correlated
.
Diverticular disease was previously considered to be a unique disease in western industrialized countries, but due to dietary changes, the current incidence in the Eastern Hemisphere may be gradually increasing
According to statistics, the number of people with inflammatory bowel disease (IBD) in the U.
Researchers conducted a retrospective single-center study that included patients over 18 years of age who were diagnosed with diverticulitis between January 2012 and December 2018 (but no IBD was previously diagnosed)
.
Then assess the development of IBD in these patients
From 2012 to 2018, a total of 2770 patients were diagnosed with diverticulitis
.
Among them, 17 were diagnosed with IBD, and the annual incidence rate per patient was 0.
Figure: The relationship between complex diverticulitis and the development of new inflammatory bowel disease
This study confirmed that patients with diverticulitis have a higher risk of developing new IBD, and this risk is most obvious in patients with complex diverticulitis
.
.
Original source:
Asad ur Rahman.
Association of Complicated Diverticulitis With Development of De Novo Inflammatory Bowel Disease.
Leave a message here